Seki, N <br/><br/>
Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.  [electronic resource] 

 -  Diabetes research and clinical practice  May 2006 
 - 135-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0168-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2005.09.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin II--blood<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Nephropathies--blood<br/>Female<br/>Genotype<br/>Humans<br/>Male<br/>Peptidyl-Dipeptidase A--blood<br/>Polymorphism, Genetic<br/>Receptor, Angiotensin, Type 2--drug effects<br/>Renin-Angiotensin System--drug effects<br/>Transforming Growth Factor beta--blood